These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

590 related items for PubMed ID: 25802138

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. General intellectual functioning as a buffer against theory-of-mind deficits in individuals at ultra-high risk for psychosis.
    Hur JW, Byun MS, Shin NY, Shin YS, Kim SN, Jang JH, Kwon JS.
    Schizophr Res; 2013 Sep; 149(1-3):83-7. PubMed ID: 23810120
    [Abstract] [Full Text] [Related]

  • 4. Social cognition in clinical "at risk" for psychosis and first episode psychosis populations.
    Thompson A, Papas A, Bartholomeusz C, Allott K, Amminger GP, Nelson B, Wood S, Yung A.
    Schizophr Res; 2012 Nov; 141(2-3):204-9. PubMed ID: 22959742
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cognitive functioning in at-risk mental states for psychosis and 2-year clinical outcome.
    Simon AE, Grädel M, Cattapan-Ludewig K, Gruber K, Ballinari P, Roth B, Umbricht D.
    Schizophr Res; 2012 Dec; 142(1-3):108-15. PubMed ID: 23025995
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Subjects at Ultra High Risk for psychosis have 'heterogeneous' intellectual functioning profile: a multiple-case study.
    Magaud E, Morvan Y, Rampazzo A, Alexandre C, Willard D, Gaillard R, Kazes M, Krebs MO.
    Schizophr Res; 2014 Feb; 152(2-3):415-20. PubMed ID: 24365404
    [Abstract] [Full Text] [Related]

  • 15. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
    Korver N, Nieman DH, Becker HE, van de Fliert JR, Dingemans PH, de Haan L, Spiering M, Schmitz N, Linszen DH.
    Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Social cognition and neurocognition as predictors of conversion to psychosis in individuals at ultra-high risk.
    Kim HS, Shin NY, Jang JH, Kim E, Shim G, Park HY, Hong KS, Kwon JS.
    Schizophr Res; 2011 Aug; 130(1-3):170-5. PubMed ID: 21620681
    [Abstract] [Full Text] [Related]

  • 18. Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial.
    Bolt LK, Amminger GP, Farhall J, McGorry PD, Nelson B, Markulev C, Yuen HP, Schäfer MR, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, Allott KA.
    Schizophr Res; 2019 Apr; 206():67-74. PubMed ID: 30558978
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Twelve-month psychosis-predictive value of the ultra-high risk criteria in children and adolescents.
    Armando M, Pontillo M, De Crescenzo F, Mazzone L, Monducci E, Lo Cascio N, Santonastaso O, Pucciarini ML, Vicari S, Schimmelmann BG, Schultze-Lutter F.
    Schizophr Res; 2015 Dec; 169(1-3):186-192. PubMed ID: 26526751
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.